Francisco Partners to Take Weave Private in $650M All-Cash Deal at a 34% Premium
Turn adjusted EBITDA and a few practice details into a directional enterprise-value range with our Healthcare Practice Valuation Calculator. Educational and directional, and no email required.
Francisco Partners has agreed to take Weave Communications (NYSE: WEAV) private in an all-cash deal valued at roughly $650 million, paying $7.40 per share, a 34% premium to Weave’s unaffected August 17, 2026 close. Weave’s front-office platform serves more than 40,000 independent and small-to-midsize medical, dental, optometry, and veterinary practice locations, combining agentic AI workflows with practice-management-system integrations to automate scheduling, patient communication, insurance verification, and payments. The deal, expected to close in Q4 2026 pending shareholder and regulatory approval, will delist Weave from the NYSE. Leadership and its Lehi, Utah headquarters remain as the company keeps investing in AI, payments, and revenue-cycle tools.
Practice front-office software is consolidating under private capital. For DSO, MSO, and independent-practice operators, a take-private of one of the largest patient-communication and payments platforms signals where growth investment is heading: agentic AI that automates scheduling, eligibility, and collections without adding staff. Freed from quarterly earnings pressure, Weave can push harder on those capabilities. It is worth watching for operators evaluating front-desk automation and RCM vendors, and for anyone tracking valuations in practice-management technology, where the 34% premium is a useful data point.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
How much is Francisco Partners paying for Weave?
Approximately $650 million in aggregate equity value, or $7.40 per share in an all-cash take-private, about a 34% premium over Weave’s unaffected closing price on August 17, 2026. The deal is expected to close in Q4 2026, after which Weave will delist from the NYSE.
What does Weave do?
Weave runs a front-office platform used by more than 40,000 independent and small-to-midsize medical, dental, optometry, and veterinary practice locations, pairing agentic AI workflows with practice-management-system integrations to automate scheduling, patient communication, insurance verification, and payments.
Why take Weave private?
Going private removes public-market quarterly earnings pressure, giving Weave capital flexibility to accelerate long-term AI, payments, and revenue-cycle investments. The company will keep its Lehi, Utah headquarters and CEO Brett White, and continue operating under the Weave brand.